Overview

OnTimeBio is developing a highly sensitive blood test to enable timely detection and monitoring of disease. OnTimeBio's unique product utilizes advanced computational approaches with cutting-edge genomic and epigenomic approaches, to enable a quantitative and exact readout of tissue dynamics across the organs of the human body in health and in disease. Applying our technology across multiple diseases, including; cancer, metabolic, autoimmune and neurodegenerative diseases, will reduce patient suffering and enable better treatment outcomes while lowering healthcare costs. For developers of novel therapeutics, our technology provides an unmatched lens to the body's response across all tissues of the targeted tissue. This allows better patient stratification and precise and swift monitoring of a patient's response to the new therapy, resulting in reduced costs and potentially higher success rates of clinical trials.